Evidence map›Paper›PMID 41168390›Full record

ArticleScientific reports2025

Computational analysis of miRNA mediated KDR gene regulation and natural VEGFR2 inhibitors from Persicaria hydropiper in hepatocellular carcinoma.

Sk Faisal Ahmed, Sunbin Samin, Amalesh Mondal, Md Fahim Islam, Hafiza Akter Laboni, Azmin Alam Ela, Tithi Mondal

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sk Faisal Ahmed *Department of Biochemistry and Microbiology, North South University, Dhaka, Bangladesh. Sk.faisal.ahmed.27@gmail.com.
Sunbin Samin *Department of Biotechnology and Genetic Engineering, Jahangirnagar University, Dhaka, Bangladesh.
Amalesh Mondal *Department of Physiology, Katwa College, Katwa, Purba Bardhaman, West Bengal, 713130, India. amaleshm@gmail.com.
Md Fahim Islam *Department of Pharmacy, Primeasia University, Dhaka, Bangladesh.
Hafiza Akter LaboniDepartment of Biotechnology and Genetic Engineering, Jahangirnagar University, Dhaka, Bangladesh.
Azmin Alam ElaDepartment of Pharmacy, Primeasia University, Dhaka, Bangladesh.
Tithi MondalDepartment of Botany, Kandra Radhakanta Kundu Mahavidyalaya, Kandra, West Bengal, 713129, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liver cancer is one of the deadliest cancers worldwide. There is a growing need for natural therapeutic options due to the rising global morbidity incidence of liver cancer. Due to its crucial function in angiogenesis, vascular endothelial growth factor (VEGF) signaling is considered as an ideal target for therapeutic intervention. In this in silico study, we have screened 16 microRNAs (miRNAs) that target the KDR gene, which encode VEGFR-2, and 113 natural compounds derived from Persicaria hydropiper for their anti-angiogenic properties. MicroRNA, hsa-miR-17-3p was identified with potentials of downregulating KDR gene, using several in silico tools. Two possible compounds- 6-Hydroxyluteolin and Isorhamnetin were also identified after performing ADMET profiling and molecular docking. Furthermore, 100 ns molecular dynamics simulations were run to evaluate the stability and conformational changes of protein-ligand complexes. This study identified one microRNA and two natural compounds that showed strong interaction with KDR and its encoded VEGFR-2 receptor, respectively. To validate their effectiveness as therapeutic agents against hepatocellular carcinoma, additional wet lab studies using in vitro and in vivo techniques are necessary.

Indexed as

Carcinoma, HepatocellularGene Expression Regulation, NeoplasticLiver NeoplasmsMicroRNAsVascular Endothelial Growth Factor Receptor-2Angiogenesis InhibitorsComputational BiologyHumansMolecular Docking SimulationMolecular Dynamics SimulationAngiogenesis InhibitorsKDR protein, humanMicroRNAsVascular Endothelial Growth Factor Receptor-2Hepatocellular carcinomaKDRMicroRNAMolecular dockingMolecular dynamics simulationVEGFR-2

Identifiers

PMID41168390
PMCPMC12575825

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.